Meditation reduces sympathetic activation and improves the quality of life in elderly patients with optimally treated heart failure: A prospective randomized study

Journal of Alternative and Complementary Medicine

Volumn 11, Issue 3, 2005, Pages 465-472

  Curiati, José Antonio ^a   Bocchi, Edimar ^a   Freire, José Octávio ^a   Arantes, Ana Claudia ^a   Braga, Márcia ^a   Garcia, Yolanda ^a   Guimarães, Guilherme ^a   Fo, Wilson Jacob ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FUROSEMIDE; HYDROCHLOROTHIAZIDE; LOSARTAN; SPIRONOLACTONE;

AGED; ARTICLE; BRAZIL; CARDIOPULMONARY HEMODYNAMICS; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXERCISE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; MEDITATION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BRAZIL; CARBAZOLES; ELECTROCARDIOGRAPHY; FEMALE; HEALTH EDUCATION; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MEDITATION; PROSPECTIVE STUDIES; QUALITY OF LIFE; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT;

EID: 22244433169     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2005.11.465     Document Type: Article

References (36)

1. Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: Rationale for preventive strategies and comprehensive disease management. Am Heart J 1997;133: 703-712.
2. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J 1991;12:951-957.
3. Kannel WB, Ho KKL, Thom T. Changing epidemiological features of cardiac failure. Br Heart J 1994;72(2 Suppl):3-9.
4. Cohn JN, Johnson GR, Shabetai R, et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure: The V-HeFT VA Cooperative Studies Group. Circulation 1993;87:V15-V16.
5. Benedict CR, Weiner DH, Johnstone DE, et al. Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: Results of the Studies of Left Ventricular Dysfunction (SOLVD) Registry. J Am Coll Cardiol 1993;22(4 Suppl A):146A-153A.
6. Benedict CR, Johnstone DE, Weiner DH, et al. Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: A report from the Registry of Studies of Left Ventricular Dysfunction. SOLVD investigators. J Am Coll Cardiol 1994;23:1410-1420.
7. Benedict CR, Shelton B, Johnstone DE, et al. Prognosis significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. Circulation 1996;94:690-697.
8. Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: A substudy of the studies of left ventricular dysfunction (SOLVD). Circulation 1990;82:1724-1729.
9. Jevning R, Wallace RK, Beidebach M. The physiology of meditation: A review. A wakeful hypometabolic integrated response. Neurosci Biobehav Rev 1992;16:415-424.
10. Infante JR, Torres-Avisbal M, Pinel P, et al. Catecholamine levels in practioners of the transcendental meditation technique. Physiol Behav 2001;72:141-146.
11. Hjemdahl P, Fagius J, Freyschuss U, et al. Muscle sympathetic activity and norepinephrine release during mental challenge in humans. Am J Physiol 1989;257:E654-E664.
12. Barrows KA, Jacobs BP. Mind-body medicine: An introduction and review of the literature. Med Clin North Am 2002;86: 11-31.
13. Lazar SW, Bush G, Gollub RL, et al. Functional brain mapping of the relaxation response and meditation. Neuroreport 2000;11:1581-1585.
14. Ho KK, Anderson KM, Kannel WB, et al. Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation 1993;88:107-115.
15. Vasan RS, Levy D. Defining diastolic heart failure: A call for standardized diagnostic criteria. Circulation 2000;102:2118-2121.
16. Benson H, with Klipper MG. The relaxation response. In: Timeless Healing, 1st ed. New York: Scribner, 1996:125-148.
17. Bouloux P, Perrett D, Besser GM. Methodological considerations in the determination of plasma catecholamines by high-performance liquid chromatography with electrochemical detection. Ann Clin Biochem 1985;22:194-203.
18. Rector TS, Kubo SH, Cohn JN. Patients' self-assessment of their congestive heart failure: II. Content, reliability and validity of a new measure-the Minnesota Living with Heart Failure questionnaire. Heart Fail 1987;3:198-209.
19. Bocchi EA, Guimarães G, Mocelin A, et al. Sildenafil effects on exercise, neurohormonal activation, and erectile dysfunction in congestive heart failure: A double-blind, placebo-controlled, randomized study followed by a prospective treatment for erectile dysfunction. Circulation 2002;106:1097-1103.
20. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-367.
21. Rakowski H, Appleton C, Chan KL, et al. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography. J Am Soc Echocardiogr 1996;9:736-760.
22. Kitzman DW, Little WC, Brubaker PH, et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002;288:2144-2150.
23. Dutka DP, Olivotto I, Ward S, et al. Effects of aging on neuroendocrine activation in subjects and patients in the presence and absence of heart failure with left ventricular systolic dysfunction. Am J Cardiol 1996;77:1197-1201.
24. Vasan RS, Larson MG, Benjamin EJ, et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: Prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999;33:1948-1955.
25. Gottdiener JS, McClelland RL, Marshall R, et al. Outcome of congestive heart failure in elderly persons: Influence of left ventricular systolic function: The Cardiovascular Health Study. Ann Intern Med 2002;137:631-639.
26. Baran D, Horn EM, Hryniewicz K, et al. Effects of β-blockers on neurohormonal activation in patients with congestive heart failure. Drugs 2000;60:997-2000.
27. Dulin B, Abraham WT. Pharmacology of carvedilol. Am J Cardiol 2004;93(9A):3B-6B.
28. Chizzola PR, Freitas, HFG, Caldas MA, et al. Effects of carvedilol in heart failure due to dilated cardiomyopathy: Results of a double-blind randomized placebo-controlled study (CARIBE Study). Arq Bras Cardiol 2000;74:238-242.
29. Kawai K, Hata K, Takaoka H, et al. Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during beta-blocker therapy: A potential of hormone-guided treatment. Am Heart J 2001;14:925-932.
30. Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: Reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Am Heart J 1992;124:1017-1025.
31. Rector TS, Kubo SH, Cohn JN. Validity of the Minnesota Living with Heart Failure Questionnaire as a measure of therapeutic response: Effects of enalapril and placebo. Am J Cardiol 1993;71:1106-1107.
32. Stanek EJ, Oates MB, McGhan WF, et al. Preferences for treatment outcomes in patients with heart failure: Symptoms versus survival. J Card Fail 2000;6:225-232.
33. Ponikowski P, Francis DP, Piepoli MF, et al. Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: Marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis. Circulation 2001;103:967-972.
34. Bernardi L, Spadacini G, Bellwon J, et al. Effect of breathing rate on oxygen saturation and exercise performance in chronic heart failure. Lancet 1998;9112:1308-1311.
35. Bernardi L, Porta C, Spicuzza L, et al. Slow breathing increases baroreflex sensitivity in patients with chronic heart failure. Circulation 2002;105:143-145.
36. Goso Y, Asanoi H, Ishise H, et al. Respiratory modulation of muscle sympathetic nerve activity in patients with chronic heart failure. Circulation 2001;104:418-423.